Sam Brusco
Associate Editor at (ODT) Orthopedic Design & Technology Magazine
Lover of MedTech, music, satire, and sci-fi. Hoping someday for an overlap. Associate Editor of MPO & ODT—views expressed are my own.
Articles
-
2 days ago |
odtmag.com | Sam Brusco
Corin announced the first total hip arthroplasty (THA) cases using its ApolloHipX, the newest application for its Apollo connected surgical ecosystem. ApolloHipX, according to the company, is the first THA solution that merges dynamic 3D preoperative planning with real-time intraoperative assessment from standard fluoroscopy. It lets surgeons deliver a personalized plan for THA.
-
2 days ago |
odtmag.com | Michael Barbella |Sam Brusco |Rachel Klemovitch
Medacta Group SA is showcasing its expanded sports medicine portfolio next week at the 15th Biennial International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS) Congress in Munich, Germany (June 8-11). Medacta bolstered its sports medicine offerings upon acquiring Parcus Medical in March from Anika Therapeutics. Among the expanded solutions being highlighted at the show (booth 03A) is the X-Twist anchor platform and Draw Tight all-suture anchor fixation systems.
-
2 days ago |
mpo-mag.com | Sam Brusco
Owens & Minor and Rotech gave mutually agreed to terminate their previously announced acquisition. Per the merger agreement, Owens & Minor paid $80 million to Rotech and will also redeem the $1 billion of notes issued in April 2025, which include a mandatory redemption provision. The company will also terminate the incremental term loan commitments and senior unsecured bridge loan commitments provided by its lenders.
-
2 days ago |
odtmag.com | Sam Brusco
Treace Medical Concepts has filed a lawsuit against Zimmer Biomet and Paragon 28, claiming the infringement of four patents related to its Lapiplasty 3D Bunion Correction technologies. The lawsuit was filed in the U.S. District Court for the District of Delaware. It seeks injunctive relief and damages. Treace’s patent portfolio includes 80 granted U.S. patents, with a further 26 granted patents worldwide and more than 150 pending patent applications.
-
3 days ago |
mpo-mag.com | Sam Brusco
Clairity has received U.S. Food and Drug Administration (FDA) de novo authorization for Clairity Breast, an image-based prognostic platform that leverages artificial intelligence (AI) to predict five-year breast cancer risk from a routine screening mammogram. The tool analyzes subtle imaging features on screening mammograms that correlate with future risk of breast cancer.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 267
- Tweets
- 875
- DMs Open
- No
RT @ODTmagazine: .@Medtronic_Spine VP and GM Carlton Weatherby discusses spinal technology with associate editor @SamISureAm. #spinesurgery…
A spotlight on the latest technologies from #spine companies of all sizes. #spinesurgery @VIVEX_Biologics @augmedics @NuVasiveInc | https://t.co/w2DxTsZDxd https://t.co/83Loqr7xFw
.@DraganflyInc's pandemic drone should help health officials fixate on outbreaks immediately as it soars above communities. #COVID19 https://t.co/Zf2y2JYVRn